Pretax income is the income that a company earns before paying income taxes. Oxford BioMedica's pretax income for the
six
months ended in Dec. 2023 was £-136.18 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was £-188.53 Mil.
Oxford BioMedica's pretax margin was -293.01%.
During the past 13 years, Oxford BioMedica's highest Pretax Margin was 13.92%. The lowest was -210.55%. And the median was -32.73%.
Oxford BioMedica Pre-Tax Income Historical Data
The historical data trend for Oxford BioMedica's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Oxford BioMedica's Pre-Tax Income
For the Biotechnology subindustry, Oxford BioMedica's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oxford BioMedica's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Oxford BioMedica's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Oxford BioMedica's Pre-Tax Income falls into.
Oxford BioMedica Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Oxford BioMedica's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-188.53 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oxford BioMedica (LSE:OXB) Pre-Tax Income Explanation
Oxford BioMedica's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, Oxford BioMedica's highest Pretax Margin was 13.92%. The lowest was -210.55%. And the median was -32.73%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oxford BioMedica Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Oxford BioMedica's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Oxford BioMedica PLC is a player in the healthcare market in the United Kingdom. As a biopharmaceutical company, it focuses on the field of immunotherapy by managing a platform of technologies for designing gene-based medicines. The company's operating segments include the Platform segment consists of the revenue-generating bioprocessing and process development activities undertaken for third parties. Its Product segment consists of the clinical and preclinical development of in vivo and ex vivo gene and cell therapy products. The company derives the maximum revenue from the Platform segment. Its Platform includes LentiVector, LentiStable, TRiPSystem, SecNuc, Analytics, and others. Geographically, it generates the majority of its revenue from Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:OXB has been successfully added to your 